Evidence map›Paper›PMID 39380896›Full record

SynthesisFrontiers in bioengineering and biotechnology2024

Cyber-biological convergence: a systematic review and future outlook.

Mariam Elgabry, Shane Johnson

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in bioengineering and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Tree-Based Methods to Predict Enzyme Inhibition.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mariam ElgabryDAWES Center for Future Crime at UCL, Jill Dando Institute for Security and Crime Science, London, United Kingdom.
Shane JohnsonDAWES Center for Future Crime at UCL, Jill Dando Institute for Security and Crime Science, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The introduction of the capability to "program" a biological system is referred to as Engineered biology and can be compared to the introduction of the internet and the capability of programming a computer. Engineered biology is supported by a digital infrastructure that includes data, data storage, computer-dependent laboratory equipment, internet-connected communication networks, and supply chains. This connectivity is important. It can improve workflows and enhance productivity. At the same time and unlike computer programs, biological systems introduce unique threats as they can self-assemble, self-repair, and self-replicate. The aim of this paper is to systematically review the cyber implications of engineered biology. This includes cyber-bio opportunities and threats as engineered biology continues to integrate into cyberspace. We used a systematic search methodology to review the academic literature, and supplemented this with a review of opensource materials and "grey" literature that is not disseminated by academic publishers. A comprehensive search of articles published in or after 2017 until the 21st of October 2022 found 52 studies that focus on implications of engineered biology to cyberspace. The search was conducted using search engines that index over 60 databases-databases that specifically cover the information security, and biology literatures, as well as the wider set of academic disciplines. Across these 52 articles, we identified a total of 7 cyber opportunities including automated bio-foundries and 4 cyber threats such as Artificial Intelligence misuse and biological dataset targeting. We highlight the 4 main types of cyberbiosecurity solutions identified in the literature and we suggest a total of 9 policy recommendations that can be utilized by various entities, including governments, to ensure that cyberbiosecurity remains frontline in a growing bioeconomy.

Indexed as

artificial intelligencebiosecuritycyberbiosecuritycyber threatsengineered biologypolicysecuritysystematic review

Identifiers

PMID39380896
PMCPMC11458441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.